rs61730896

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004208.4(AIFM1):​c.103C>T​(p.Pro35Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000975 in 1,189,312 control chromosomes in the GnomAD database, including 6 homozygotes. There are 322 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0046 ( 3 hom., 153 hem., cov: 24)
Exomes 𝑓: 0.00059 ( 3 hom. 169 hem. )

Consequence

AIFM1
NM_004208.4 missense

Scores

4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.47

Publications

5 publications found
Variant links:
Genes affected
AIFM1 (HGNC:8768): (apoptosis inducing factor mitochondria associated 1) This gene encodes a flavoprotein essential for nuclear disassembly in apoptotic cells, and it is found in the mitochondrial intermembrane space in healthy cells. Induction of apoptosis results in the translocation of this protein to the nucleus where it affects chromosome condensation and fragmentation. In addition, this gene product induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Mutations in this gene cause combined oxidative phosphorylation deficiency 6 (COXPD6), a severe mitochondrial encephalomyopathy, as well as Cowchock syndrome, also known as X-linked recessive Charcot-Marie-Tooth disease-4 (CMTX-4), a disorder resulting in neuropathy, and axonal and motor-sensory defects with deafness and cognitive disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 10. [provided by RefSeq, Aug 2015]
RAB33A (HGNC:9773): (RAB33A, member RAS oncogene family) The protein encoded by this gene belongs to the small GTPase superfamily, Rab family. It is GTP-binding protein and may be involved in vesicle transport. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008270264).
BP6
Variant X-130165554-G-A is Benign according to our data. Variant chrX-130165554-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136326.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00462 (521/112787) while in subpopulation AFR AF = 0.016 (498/31128). AF 95% confidence interval is 0.0148. There are 3 homozygotes in GnomAd4. There are 153 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIFM1NM_004208.4 linkc.103C>T p.Pro35Ser missense_variant Exon 1 of 16 ENST00000287295.8 NP_004199.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIFM1ENST00000287295.8 linkc.103C>T p.Pro35Ser missense_variant Exon 1 of 16 1 NM_004208.4 ENSP00000287295.3 O95831-1
AIFM1ENST00000675092.1 linkc.103C>T p.Pro35Ser missense_variant Exon 1 of 16 ENSP00000501772.1 A0A6Q8PFE1

Frequencies

GnomAD3 genomes
AF:
0.00461
AC:
520
AN:
112737
Hom.:
3
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0160
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00103
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000364
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.0000563
Gnomad OTH
AF:
0.00458
GnomAD2 exomes
AF:
0.00136
AC:
192
AN:
141189
AF XY:
0.000932
show subpopulations
Gnomad AFR exome
AF:
0.0166
Gnomad AMR exome
AF:
0.000755
Gnomad ASJ exome
AF:
0.000149
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000348
Gnomad OTH exome
AF:
0.00162
GnomAD4 exome
AF:
0.000593
AC:
638
AN:
1076525
Hom.:
3
Cov.:
30
AF XY:
0.000481
AC XY:
169
AN XY:
351005
show subpopulations
African (AFR)
AF:
0.0194
AC:
502
AN:
25941
American (AMR)
AF:
0.00107
AC:
35
AN:
32584
Ashkenazi Jewish (ASJ)
AF:
0.0000528
AC:
1
AN:
18933
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29067
South Asian (SAS)
AF:
0.0000389
AC:
2
AN:
51473
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38906
Middle Eastern (MID)
AF:
0.00219
AC:
9
AN:
4105
European-Non Finnish (NFE)
AF:
0.0000241
AC:
20
AN:
830302
Other (OTH)
AF:
0.00153
AC:
69
AN:
45214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00462
AC:
521
AN:
112787
Hom.:
3
Cov.:
24
AF XY:
0.00438
AC XY:
153
AN XY:
34945
show subpopulations
African (AFR)
AF:
0.0160
AC:
498
AN:
31128
American (AMR)
AF:
0.00102
AC:
11
AN:
10735
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3591
South Asian (SAS)
AF:
0.000366
AC:
1
AN:
2735
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6212
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.0000563
AC:
3
AN:
53290
Other (OTH)
AF:
0.00453
AC:
7
AN:
1546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000928
Hom.:
58
Bravo
AF:
0.00557
ESP6500AA
AF:
0.0149
AC:
57
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00134
AC:
159

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 23, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Charcot-Marie-Tooth disease X-linked recessive 4;C1845095:Deafness, X-linked 5;C1846148:Spondyloepimetaphyseal dysplasia, Bieganski type;C3151753:Severe X-linked mitochondrial encephalomyopathy Benign:1
Dec 15, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Severe X-linked mitochondrial encephalomyopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Combined oxidative phosphorylation deficiency;CN118851:Charcot-Marie-Tooth Neuropathy X Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
.;.;.;T
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.48
T;T;.;T
MetaRNN
Benign
0.0083
T;T;T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.1
M;M;M;M
PhyloP100
1.5
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.47
N;N;.;N
REVEL
Benign
0.022
Sift
Uncertain
0.012
D;T;.;T
Sift4G
Uncertain
0.040
D;T;T;T
Polyphen
0.31
B;B;.;B
Vest4
0.41
MVP
0.88
MPC
0.65
ClinPred
0.012
T
GERP RS
2.8
PromoterAI
0.096
Neutral
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.1
Varity_R
0.096
gMVP
0.54
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61730896; hg19: chrX-129299528; API